Nisa Investment Advisors
MBX

Nisa Investment Advisors’s MBX Biosciences MBX Stock Holding History

Nisa Investment Advisors’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Buy
2,013
+421
+26% +$14.7K ﹤0.01% 1496
2026
Q1 		$47.5K Hold
1,592
– – ﹤0.01% 1687
2025
Q4 		$50.2K Hold
1,592
– – ﹤0.01% 1612
2025
Q3 		$27.9K Hold
1,592
– – ﹤0.01% 1844
2025
Q2 		$18.2K Buy
+1,592
New +$16.2K ﹤0.01% 1988

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Nisa Investment Advisors's MBX Position: Q2 2026 in Review

Nisa Investment Advisors increased its MBX Biosciences (MBX) stake by 26% in Q2 2026, buying an estimated $14.7K and bringing the position to 2,013 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #1496.

Nisa Investment Advisors first reported a position in MBX in Q2 2025 and has held it in 5 quarters since. 172 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • Nisa Investment Advisors held 2,013 shares of MBX Biosciences worth $111K as of Q2 2026.
  • Nisa Investment Advisors bought 421 MBX Biosciences shares in Q2 2026, an estimated $14.7K.
  • MBX Biosciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1496 holding.
  • Nisa Investment Advisors first reported a position in MBX Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 172 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.